COVID-19 epidemiology and demographics

Jump to navigation Jump to search

COVID-19 Microchapters

Home

Long COVID

Frequently Asked Outpatient Questions

Frequently Asked Inpatient Questions

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating COVID-19 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Vaccines

Secondary Prevention

Future or Investigational Therapies

Ongoing Clinical Trials

Case Studies

Case #1

COVID-19 epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of COVID-19 epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on COVID-19 epidemiology and demographics

CDC on COVID-19 epidemiology and demographics

COVID-19 epidemiology and demographics in the news

Blogs on COVID-19 epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for COVID-19 epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]

Overview

Globally, 3,755,341 cases of COVID-19 have been reported with 263,831 deaths. In the US, more than 1 million cases have been reported with 73,431 deaths in the country. Due to rapidly evolving data at this point, the exact incidence rate of Coronavirus disease 2019 (COVID-19) can not be approximated. Prevalent in all the continents of the world, World Health Organization (WHO) has declared COVID-19 outbreak a pandemic. Due to inconsistent reporting and lack of organized data, an exact and universal case-fatality rate of COVID-19 is yet to be established. Middle aged and elderly population seem to be the most commonly affected with a median age of 49 - 56 years. COVID-19 is affecting males more than females. Majority of the cases of COVID-19 were first reported in China and at this point the disease has spread to all the continents of the world.

Epidemiology and Demorgraphics

Incidence

  • Due to the lack of broad screening data at this point, the exact incidence rate of Coronavirus disease 2019 (COVID-19) can not be approximated.

Prevalence

  • To date, 3,755,341 confirmed cases of COVID-19 have emerged globally.
  • In the US, more than 1 million cases have been reported with 73,431 deaths in the country.
  • Epidemiologist Mark Lipsitch has suggested that 40% of the world's population could get infected with coronavirus.[1] This assertion may be based on a non-peer-reviewed studies.[2][3].
  • Prevalent in all the continents of the world, World Health Organization (WHO) has declared COVID-19 outbreak a pandemic.
  • For details on the real-time prevalence and spread of COVID-19, click here.[4][5][6][7][8]
  • Among patients iwth influenza-like-illness and without risk factors for COVID-19, 5% were positive for COVID-19.[9]

Case-fatality rate

  • The case fatality-rate of COVID-19 in the first 99 patients at a Wuhan hospital (the epicenter of the outbreak) was found to be 11%.[10]
  • In a different study comprising of 138 patients infected with COVID-19, the mortality has been established to be 4.3%.[11]
  • Due to inconsistent reporting and lack of organized data, an exact and universal case-fatality rate of COVID-19 is yet to be established.
  • In Wuhan, the case-fatality was 5.8% and in the rest of China it was 0.7%.[12]
  • The CDC states "Lower estimates [0.6%] might be closest to the true value, but a broad range of 0.25%–3.0% probably should be considered."[13]

Age

  • COVID-19 can affect individuals of any age.
  • Middle aged and elderly population seem to be the most commonly affected.
  • In multiple cohorts of patients hospitalized with confirmed COVID-19, the median age is established to range from 49 to 56 years.[14][15][16]
  • In a report including approximately 44,500 cases, 87% of the patients were between the ages of 30 and 79 years.[17]
  • According to the same report mentioned above, 2% of the patients were younger than the age of 20 years.
  • Children account for < 2% of #COVID19 possibly due to lower expression of angiotensin-converting enzyme 2 (ACE2), the receptor the virus uses for entry into cells. ACE2 gene expression in the nasal epithelium is now shown to be lower as age decreased. This hypothesis has now found some support in this study showing children have lower ACE2 gene expression in the nasal epithelium, but the causal role has yet to be firmly established. More data is needed but this is provocative[18]

Race

  • At this point, there seems to be no racial predilection to COVID-19.
  • In Baltimore/DC area, the #COVID19 positivity rate for Latino patients was 42.6%, significantly higher than the rate for white patients (8.8%), black patients (17.6%), or those of other race/ethnicity (17.2%) (P < .001 for each pairwise comparison)[19]

Gender

  • COVID-19 is affecting males more than females.[20][21]

Region

  • Majority of the cases of COVID-19 were first reported in China and at this point the disease has spread to all the continents of the world.
  • In the United States, confirmed cases of COVID-19 have been reported in all of the 50 States.[22]
  • For real-time details regarding the worldwide spread of COVID-19, click here.[4][5][6][7][8]
  • For real-time details regarding the spread of COVID-19 in the US, click here.[23]

References

  1. ↑ Anoymouis (2020) The latest on the coronavirus. T.H. Chan. Harvard School of Public Health. Avaiable at: https://www.hsph.harvard.edu/news/hsph-in-the-news/the-latest-on-the-coronavirus/ (search the page for instances of '40%')
  2. ↑ Niehus, Rene; De Salazar, Pablo M; Taylor, Aimee; Lipsitch, Marc (2020). doi:10.1101/2020.02.13.20022707. Missing or empty |title= (help)
  3. ↑ De Salazar, Pablo M; Niehus, Rene; Taylor, Aimee; Buckee, Caroline O; Lipsitch, Marc (2020). doi:10.1101/2020.02.04.20020495. Missing or empty |title= (help)
  4. ↑ 4.0 4.1 https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6. Missing or empty |title= (help)
  5. ↑ 5.0 5.1 Dong, Ensheng; Du, Hongru; Gardner, Lauren (2020). "An interactive web-based dashboard to track COVID-19 in real time". The Lancet Infectious Diseases. doi:10.1016/S1473-3099(20)30120-1. ISSN 1473-3099.
  6. ↑ 6.0 6.1 "WHO statement regarding cluster of pneumonia cases in Wuhan, China".
  7. ↑ 7.0 7.1 "Coronavirus disease 2019 (COVID-19) situation reports".
  8. ↑ 8.0 8.1 "Tracking the epidemic".
  9. ↑ Spellberg, Brad; Haddix, Meredith; Lee, Rebecca; Butler-Wu, Susan; Holtom, Paul; Yee, Hal; Gounder, Prabhu (2020). "Community Prevalence of SARS-CoV-2 Among Patients With Influenzalike Illnesses Presenting to a Los Angeles Medical Center in March 2020". JAMA. doi:10.1001/jama.2020.4958. ISSN 0098-7484.
  10. ↑ Huang, Chaolin; Wang, Yeming; Li, Xingwang; Ren, Lili; Zhao, Jianping; Hu, Yi; Zhang, Li; Fan, Guohui; Xu, Jiuyang; Gu, Xiaoying; Cheng, Zhenshun; Yu, Ting; Xia, Jiaan; Wei, Yuan; Wu, Wenjuan; Xie, Xuelei; Yin, Wen; Li, Hui; Liu, Min; Xiao, Yan; Gao, Hong; Guo, Li; Xie, Jungang; Wang, Guangfa; Jiang, Rongmeng; Gao, Zhancheng; Jin, Qi; Wang, Jianwei; Cao, Bin (2020). "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China". The Lancet. doi:10.1016/S0140-6736(20)30183-5. ISSN 0140-6736.
  11. ↑ Wang, Dawei; Hu, Bo; Hu, Chang; Zhu, Fangfang; Liu, Xing; Zhang, Jing; Wang, Binbin; Xiang, Hui; Cheng, Zhenshun; Xiong, Yong; Zhao, Yan; Li, Yirong; Wang, Xinghuan; Peng, Zhiyong (2020). "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China". JAMA. doi:10.1001/jama.2020.1585. ISSN 0098-7484.
  12. ↑ (PDF) https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. Missing or empty |title= (help)
  13. ↑ Wilson, Nick; Kvalsvig, Amanda; Barnard, Lucy Telfar; Baker, Michael G. (2020). "Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality". Emerging Infectious Diseases. 26 (6). doi:10.3201/eid2606.200320. ISSN 1080-6040.
  14. ↑ Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (February 2020). "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China". Lancet. 395 (10223): 497–506. doi:10.1016/S0140-6736(20)30183-5. PMID 31986264.
  15. ↑ Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L (February 2020). "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study". Lancet. 395 (10223): 507–513. doi:10.1016/S0140-6736(20)30211-7. PMID 32007143 Check |pmid= value (help).
  16. ↑ Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (February 2020). "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China". JAMA. doi:10.1001/jama.2020.1585. PMID 32031570 Check |pmid= value (help).
  17. ↑ Wu Z, McGoogan JM (February 2020). "Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention". JAMA. doi:10.1001/jama.2020.2648. PMID 32091533 Check |pmid= value (help).
  18. ↑ Bunyavanich, Supinda; Do, Anh; Vicencio, Alfin (2020). "Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults". JAMA. 323 (23): 2427. doi:10.1001/jama.2020.8707. ISSN 0098-7484.
  19. ↑ Martinez, Diego A.; Hinson, Jeremiah S.; Klein, Eili Y.; Irvin, Nathan A.; Saheed, Mustapha; Page, Kathleen R.; Levin, Scott R. (2020). "SARS-CoV-2 Positivity Rate for Latinos in the Baltimore-Washington, DC Region". JAMA. doi:10.1001/jama.2020.11374. ISSN 0098-7484.
  20. ↑ Li, Qun; Guan, Xuhua; Wu, Peng; Wang, Xiaoye; Zhou, Lei; Tong, Yeqing; Ren, Ruiqi; Leung, Kathy S.M.; Lau, Eric H.Y.; Wong, Jessica Y.; Xing, Xuesen; Xiang, Nijuan; Wu, Yang; Li, Chao; Chen, Qi; Li, Dan; Liu, Tian; Zhao, Jing; Liu, Man; Tu, Wenxiao; Chen, Chuding; Jin, Lianmei; Yang, Rui; Wang, Qi; Zhou, Suhua; Wang, Rui; Liu, Hui; Luo, Yinbo; Liu, Yuan; Shao, Ge; Li, Huan; Tao, Zhongfa; Yang, Yang; Deng, Zhiqiang; Liu, Boxi; Ma, Zhitao; Zhang, Yanping; Shi, Guoqing; Lam, Tommy T.Y.; Wu, Joseph T.; Gao, George F.; Cowling, Benjamin J.; Yang, Bo; Leung, Gabriel M.; Feng, Zijian (2020). "Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia". New England Journal of Medicine. doi:10.1056/NEJMoa2001316. ISSN 0028-4793.
  21. ↑ Yang, Yongshi; Peng, Fujun; Wang, Runsheng; Guan, Kai; Jiang, Taijiao; Xu, Guogang; Sun, Jinlyu; Chang, Christopher (2020). "The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China". Journal of Autoimmunity: 102434. doi:10.1016/j.jaut.2020.102434. ISSN 0896-8411.
  22. ↑ https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html. Missing or empty |title= (help)
  23. ↑ https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html. Missing or empty |title= (help)
Retrieved from "https://www.wikidoc.org/index.php?title=COVID-19_epidemiology_and_demographics&oldid=1617081"